Acute liver failure laboratory findings
Acute liver failure Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Acute liver failure laboratory findings On the Web |
American Roentgen Ray Society Images of Acute liver failure laboratory findings |
Risk calculators and risk factors for Acute liver failure laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Husnain Shaukat, M.D [2]
Overview
Acute liver failure can present with nonspecific symptoms and it occurs in healthy individuals without a previous history of liver disease. So, the initial labs in the acute liver failure are planned to evaluate both the etiology and the severity of the disease. All patients with clinical or laboratory evidence of moderate to severe acute hepatitis should have an immediate measurement of prothrombin time and careful evaluation of mental status. If the prothrombin time is prolonged (INR ≥1.5) and there is any evidence of altered sensorium, the diagnosis of acute liver failure should be strongly suspected and hospital admission is mandatory.
Laboratory Findings
- Acute liver failure can present with nonspecific symptoms and it occurs in healthy individuals without a previous history of liver disease. So, the initial labs in the acute liver failure are planned to evaluate both the etiology and the severity of the disease.[1][2][3][4]
LAB | values in Acute liver failure | Comments |
---|---|---|
|
| |
|
| |
|
| |
|
|
|
|
| |
|
| |
|
| |
|
| |
|
|
|
|
|
|
|
| |
|
||
|
|
References
- ↑ Polson J, Lee WM (2005). "AASLD position paper: the management of acute liver failure". Hepatology. 41 (5): 1179–97. doi:10.1002/hep.20703. PMID 15841455.
- ↑ Wasley A, Fiore A, Bell BP (2006). "Hepatitis A in the era of vaccination". Epidemiol Rev. 28: 101–11. doi:10.1093/epirev/mxj012. PMID 16775039.
- ↑ Khuroo MS, Kamili S (2003). "Aetiology and prognostic factors in acute liver failure in India". J. Viral Hepat. 10 (3): 224–31. PMID 12753342.
- ↑ Torres HA, Davila M (2012). "Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer". Nat Rev Clin Oncol. 9 (3): 156–66. doi:10.1038/nrclinonc.2012.1. PMID 22271089.